Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

Samuel recreated this phenomenon in a lab to prove that it occurs during actual plasmid transfer between bacteria. “We used plasmids that confer antibiotic resistance and introduced them into bacteria ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...

2.5 Establishment of BCoV CRISPR/Cas13a assay combined RT-RAA The BCoV-Cas13a assays combined RT-RAA reaction and LwCas13a trans-cleavage system containing T7 transcription were established. For ...

This method allowed us to easily test the conditions under which the plasmid could overcome the defense system — if it succeeds in overcoming the CRISPR system, the recipient bacteria become ...

This method allowed us to easily test the conditions under which the plasmid could overcome the defense system—if it succeeds in overcoming the CRISPR system, the recipient bacteria become ...

Generating a large number of pairs of gRNAs, such as through CRISPR screens (Schmidt et al ... dCas9-p300 was cloned into a lentiviral plasmid backbone (Addgene# 83889) was a gift from Gersbach lab.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...